Latest Strategy News

AIC Mines reports robust production and cash flow from Eloise, advances Jericho development with promising drilling, and kicks off a major processing plant expansion.

Aurelia Metals has revealed significant exploration success at its Nymagee Mine in NSW, discovering two new mineral lenses and extending known mineralisation with promising gold and base metal grades.

Enero Group’s 2025 AGM revealed a modest revenue dip but a rise in EBITDA, driven by operational improvements and AI innovation. The company’s FY26 Q1 update signals robust momentum with margin expansion and strategic client wins.

Enero Group reports improved profitability in FY25 despite revenue decline, driven by divestment and AI innovation, with FY26 Q1 EBITDA up 13%.

MyEco Group reported a modest 2% rise in Q1 FY26 sales, driven by a doubling in council and waste channel revenues despite ongoing headwinds from U.S. tariff changes impacting white label sales.

Treasury Wine Estates reported robust fiscal 2025 results driven by luxury wine growth and acquisitions, yet has downgraded its fiscal 2026 earnings outlook due to weakening demand in China and distribution disruptions in California.

Eclipse Metals has commenced diamond drilling at its Greenland rare earth project, backed by a $4 million placement to expand and upgrade its resource. The move aligns with strategic plans for a Nasdaq dual listing amid growing global supply chain concerns.

Nanoveu Limited showcased its cutting-edge EMASS semiconductor technology at the Ignite Investment Summit in Hong Kong, highlighting a new ultra-low-power AI chip designed to revolutionize edge computing across multiple industries.

Battery Age Minerals (ASX – BM8) showcased its global portfolio of critical minerals projects at the Ignite Investment Summit in Hong Kong, highlighting maiden drilling at Austria’s Bleiberg germanium project, a newly granted drill permit for Argentina’s El Aguila gold-silver system, and ongoing lithium exploration in Canada’s Falcon Lake.

European Lithium Limited signals a likely change to the timetable for its replacement options offer as 208 million options approach expiry in November. Investors await updated details amid potential capital structure implications.

EMVision Medical Devices’ latest Share Purchase Plan has attracted applications exceeding its initial $1 million target, with limited oversubscription capacity remaining ahead of the October 23 closing date.

NSX Limited’s shares have been suspended from trading following Federal Court approval of its acquisition by an Ontario-based entity linked to CNSX Markets Inc. This marks a significant shift in ownership for the Australian stock exchange operator.